Cadila Healthcare clears USFDA inspection at Ahmedabad SEZ facility

Company is expecting a strong US growth rate with ~50 product launches and this must require all facilities remain in full compliance.

from India Infoline News Service https://ift.tt/2LqLyx5

Comments

Popular posts from this blog

What are the key measures of market volatility?